Livia Manzella

Catania, 95123, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Clinical Implications of UGT1A1 Polymorphisms in Anticancer Therapy: An Updated Review.

Clinical Implications of UGT1A1 Polymorphisms in Anticancer Therapy: An Updated Review.

Journal: Pharmaceutics

Published: June 29, 2026

Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic Implications.

Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic Implications.

Journal: Critical reviews in oncology/hematology

Published: April 10, 2026

Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIs.

Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIs.

Journal: Frontiers in pharmacology

Published: January 03, 2026

Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage Model.

Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage Model.

Journal: Genes

Published: December 13, 2025

The Coiled Coil and C2 Domains Modulate BCR Localization and BCR-ABL1 Compartmentalization, Transforming Activity and TKI Responsiveness.

The Coiled Coil and C2 Domains Modulate BCR Localization and BCR-ABL1 Compartmentalization, Transforming Activity and TKI Responsiveness.

Journal: International journal of molecular sciences

Published: June 15, 2025

No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level.

No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level.

Journal: International journal of molecular sciences

Published: December 23, 2024

An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma.

An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma.

Journal: Biomolecules

Published: September 03, 2024

In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients.

In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients.

Journal: Genes

Published: June 28, 2024

HER2-Low Expression in Male Breast Cancer: Results from a Multicenter Series in Italy.

HER2-Low Expression in Male Breast Cancer: Results from a Multicenter Series in Italy.

Journal: Cancers

Published: December 18, 2023

Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer.

Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer.

Journal: Genes

Published: May 22, 2023

High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability.

High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability.

Journal: OncoTargets and therapy

Published: April 06, 2023

Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study.

Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 06, 2023

Showing 1-12 of 61

Last Updated: 09/26/2026